Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-11-09FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride by Teva Pharmaceuticals USA, Inc., authorizing changes to the produc…
-
FDA approval · 2022-11-08FDA Approved: QUVIVIQ — Supplemental Application (Idorsia Pharmaceuticals Ltd)
FDA approved a supplemental application for QUVIVIQ (daridorexant) from Idorsia Pharmaceuticals Ltd, updating the product labeling for the t…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Reducing Health Disparities for Black Women in the Treatment of Insomnia [NA]
A completed clinical trial focused on reducing health disparities for Black women in treating insomnia; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia [Phase 3]
Phase 3 trial for SAGE-217 in adults with comorbid Major Depressive Disorder and Insomnia was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder [Phase 4]
A Phase 4 study evaluated the efficacy of suvorexant for insomnia associated with bipolar disorder; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-10-04Clinical Trial Update: Temperature Manipulating Gloves for the Treatment of Insomnia [NA]
A terminated clinical trial evaluating temperature-manipulating gloves for insomnia; results posted, indicating completion without continuin…
-
FDA approval · 2022-09-28FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for zolpidem tartrate from Sandoz Inc, enabling an updated/expanded approval for the generic pro…
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis [NA]
A completed clinical trial investigating whether reducing cannabis use affects sleep among adults using medical cannabis.
-
FDA approval · 2022-09-12FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for zolpidem tartrate submitted by Torrent Pharmaceuticals Limited. This action supports the continu…
-
FDA approval · 2022-09-02FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for zolpidem tartrate submitted by NorthStar Rx LLC.
-
FDA approval · 2022-09-02FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for zolpidem tartrate submitted by Lupin Pharmaceuticals, Inc. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder [Phase 4]
Phase 4 trial evaluating pimavanserin for insomnia in veterans with PTSD has completed and results posted.
-
FDA approval · 2022-08-09FDA Approved: TEMAZEPAM — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Temazepam from Actavis Pharma, Inc., making a generic Temazepam product eligible for marketi…
-
FDA approval · 2022-08-03FDA Approved: TEMAZEPAM — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Temazepam from Ascend Laboratories, LLC, enabling a generic Temazepam product to be marketed…
-
FDA approval · 2022-06-30FDA Approved: RAMELTEON — Supplemental Application (Dr.Reddys Laboratories Inc)
The FDA approved a supplemental application for ramelteon submitted by Dr. Reddy's Laboratories (ANDA 091693) related to the ramelteon produ…
-
FDA approval · 2022-06-24FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original application for doxepin hydrochloride as a generic product manufactured by Novadoz Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
FDA approval · 2022-05-31FDA Approved: IBUPROFEN PM — Original Application (KROGER COMPANY)
FDA approved Kroger's Ibuprofen PM, an over-the-counter combination product containing ibuprofen and diphenhydramine citrate, under an origi…
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder [Phase 2]
A Phase 2 study evaluating the efficacy, safety, and tolerability of JNJ-42847922 in adults with insomnia has completed and results have bee…
-
FDA approval · 2022-05-05FDA Approved: RAMELTEON — Supplemental Application (TruPharma, LLC)
FDA approved a supplemental application for ramelteon submitted by TruPharma, LLC.
-
FDA approval · 2022-03-28FDA Approved: RAMELTEON — Supplemental Application (Granules Pharmaceuticals Inc.)
The FDA approved a supplemental application for Granules Pharmaceuticals' generic ramelteon, enabling market entry for the treatment of inso…
-
FDA approval · 2022-03-11FDA Approved: DAYVIGO — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for DAYVIGO (lemborexant) from Eisai Inc.
-
FDA approval · 2022-02-23FDA Approved: AMBIEN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Ambien (zolpidem tartrate) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2022-02-23FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for zolpidem tartrate submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2022-02-09FDA Approved: DOXEPIN HYDROCHLORIDE — Original Application (First Nation Group, LLC)
FDA approved the original application for a generic doxepin hydrochloride product from First Nation Group, LLC, enabling its marketing in th…